130 results about "Human stomach" patented technology

The invention discloses shell-broken ganoderma spore powder and particle combination and a preparation method thereof. Shell-broken ganoderma spore powder is extracted, centrifuged, concentrated, dried and crushed to obtain the shell-broken ganoderma spore powder and particle combination, the content of crude polysaccharide in the shell-broken ganoderma spore powder and particle combination is 10-20g / 100g, and the content of total triterpene in the shell-broken ganoderma spore powder and particle combination is 4-10g / 100g. The shell-broken ganoderma spore powder and particle combination has the advantages that immunities are enhanced, radiation hazards are reduced in an auxiliary manner, the shell-broken ganoderma spore powder is treated by the aid of a special process, the content of effective components are increased, nutrient components in the effective components can be effectively absorbed by human bodies, functions of the shell-broken ganoderma spore powder are effectively played, the shell-broken ganoderma spore powder is conveniently carried and taken, the shell-broken ganoderma spore powder and particle combination has an inhibiting effect on zebra fish human stomach cancer transplantation tumors, human lung cancer transplantation tumors and human lymphocyte cancer transplantation tumors, and the shell-broken ganoderma spore powder and particle combination has a strong inhibiting effect on the zebra fish human stomach cancer transplantation tumors and the human lymphocyte cancer transplantation tumors.

The present invention relates to an indirubin-3′-oxime derivative as potent cyclin dependent kinase inhibitor with anti-cancer activity. More particularly, this invention relates to an indirubin-3′-oxime derivative as potent cyclin dependent kinase inhibitor having excellent anti-cancer activity against human lung cancer cell, human fibro sarcoma cell, human colon cancer cell, human leukemia cell, human stomach cancer cell, human nasopharyngeal cancer cell and / or human breast cancer cell.

A gastric restrictive device positionable around a human stomach to limit the flow of food therethrough is provided with structure for facilitating suturing of the gastric restrictive device to the stomach and thereby preventing movement of the gastric restrictive device relative to the stomach.

The invention discloses an extract of Ginkgo Biloba leaves-cyclodextrin derivative inclusion compound and a preparation method thereof, which is prepared from 10 to 24 percent of total flavonol glycoside, 2 to 6 percent of terpene lactone and 70 to 88 percent of cyclodextrin derivative and auxiliary materials, according to the weight percentage; the preparing method comprises the following steps: dissolving cyclodextrin derivative in water, adding extract of Ginkgo Biloba leaves; stirring for 6 to 8 hours; reducing the pressure and vacuum drying at the temperature of 55 to 65 DEG C; and obtaining the extract of Ginkgo Biloba leaves-cyclodextrin derivative inclusion compound in a solid grinding way. The invention adopts an inclusion technology to greatly enhance the dissolubility and the dissolution of the ginkgo leaves in the water, to enhance the absorption in human stomach and intestine, and to simultaneously greatly increase the stability of the principal components in the extract of Ginkgo Biloba leaves, the extract of Ginkgo Biloba leaves and terpene lactones after being processed by adopting the inclusion technology. The extract of Ginkgo Biloba leaves, after being processed by adopting the inclusion technology, is 1 to 2 times higher than the ordinary preparation in bioavailability, and can be used for preparing the drugs for improving the disease of cardio-cerebrovascular systems, and preventing and remedying coronary heart diseases.

The invention discloses a dynamic human stomach-duodenum in-vitro bionic digestive system comprising a heating incubator and an esophagus model, a stomach model, a duodenum model, peristaltic extrusion devices and a digestion emptying unit which are located in the heating incubator, and the esophagus model, the stomach model and the duodenum model are connected with one another; the peristaltic extrusion devices are arranged on the two sides of the esophagus model, the stomach model and the duodenum model respectively and used for achieving bionic movement of the esophagus model, the stomach model and the duodenum model; and the digestion emptying unit comprises a feeding device connected with an inlet of the esophagus model, a digestive juice adding device connected with the stomach modeland the duodenum model, and an emptying device connected with an outlet end of the duodenum model. According to the dynamic human stomach-duodenum in-vitro bionic digestive system in the invention, the digestive process of the stomach and the duodenum of a human body can be truly simulated, accurate test data is provided for researching the digestive system of the human body, and meanwhile animalexperiments and human body experiments can be properly reduced to a certain extent.

The invention relates to compound loquat buccal tablets and a preparation method thereof. Based on loquat, olive, almond, tangerine peel, platycodon grandiflorum, mulberry, chrysanthemum, licorice and the like are added; and the buccal tablets have main effects of clearing heat from throat, drying damp, eliminating phlegm, relieving cough and asthma, dispelling wind and dissipating heat, and relieve the symptoms such as cough with lung heat, mouth parching and tongue scorch, swelling and pain in throat, phlegm obstruction and asthma caused by wind heat. The buccal tablets are prepared from medicinal and edible materials, and are exquisite in formula, safe and effective by extraction and concentration of active ingredients and convenient to carry and use; and because the active medicinal ingredients can be directly absorbed through oral mucosa in the oral taking process, loss of nutrition and medicinal ingredients absorbed by organs such as human stomach, intestines and liver is avoided, and the absorption and utilization rate of the medicinal ingredients is improved. The compound loquat buccal tablets have important value and make great contribution to clinical health care and the like, and have comprehensive effects which are superior to those of similar products in the market; and a new optional formulation is provided for clinical patients.

An enzyme having an activity of transferring N-acetylglucosamine to the non-reducing end of a Galβ1-4Glc or Galβ1-4GlcNAc-group via a β-1,3 bond; a nucleic acid encoding the same; and a method of diagnosing cancer and / or tumor, in particular, digestive cancer and / or tumor using the expression dose of a gene of the above enzyme as an indication. A gene of a novel enzyme having an activity of transferring N-acetylglucosamine to the non-reducing end of a Gal β1-4Glc or Gal β1-4GlcNAc-group via a β-1,3 bond is cloned from human stomach cells and its base sequence is determined. Then this enzyme is expressed. Since this enzyme is scarcely or never produced in cancer and / or tumor, in particular, digestive cancer and / or tumor cells, cancer and / or tumor can be diagnosed with the use of the expression of the enzyme gene as an indication.